When was Creative Enzymes founded?

Creative Enzymes was founded in 2011.

Where is Creative Enzymes located?

Creative Enzymes is headquartered in New York City, United States.

How many employees does Creative Enzymes have?

As of Sep 30, 2026, the latest employee count at Creative Enzymes is 6.

Where does Creative Enzymes rank among its competitors?

Creative Enzymes ranks 8th amongst 93 active competitors, of which 18 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was EnginZyme, which secured $7.6M in Sep, 2026.

Who are the top competitors of Creative Enzymes?

Creative Enzymes' top competitors include Debut, Codexis and EnginZyme. Among them, EnginZyme secured the most recent funding round in September, 2026.

Creative Enzymes - 2026 Company Profile & Competitors

Creative Enzymes is an unfunded company based in New York City (United States), founded in 2011. It operates as an Enzymes, probiotics, and extracts for research, diagnostics, and industrial applications. Creative Enzymes has not raised any funding yet. The company has 93 active competitors, including 18 funded and 16 that have exited. Its top competitors include companies like Debut, Codexis and EnginZyme.

Company Details

Enzymes, probiotics, and extracts for research, diagnostics, and industrial applications. The company specializes in manufacturing and supplying a wide range of enzymes, probiotics, extracts, zymogens, coenzymes, lipids, nanozymes, bacteriophages, substrates, and inhibitors. These products cater to diverse sectors, including industrial use, agriculture, biofuels, chemical processing, waste management, food and beverage, health, nutrition, animal feed, textiles, leather, pulp and paper, research, diagnostics, and bioanalysis. The company offers custom enzyme and probiotic blends, along with comprehensive services such as enzyme discovery, screening, synthesis, engineering, modification, conjugation, biocatalysis, expression, purification, stabilization, and formulation. The company supports research and development through experiment consulting, design services, enzymology assays, substrate and inhibitor screening, and enzyme catalytic mechanism analysis. The company serves academic, commercial, and governmental laboratories worldwide, providing high-quality products and services for life science research and various industrial applications.

Website: www.creative-enzymes.com/
Social
Email ID: *****@creative-enzymes.com
Phone Number: +1 **********, +1 **********

Key Metrics

Founded Year

2011

Location

New York City, United States

Stage

Unfunded

Ranked

8^th among 93 active competitors

Employee Count

6 as on Sep 30, 2026

Similar Companies

Debut & 105 more

View Creative Enzymes' full profile

Creative Enzymes has not raised any funding rounds yet.

Creative Enzymes' employee count trend

Creative Enzymes has 6 employees as of Sep 26. Here is Creative Enzymes's employee count trend over the years:

Employee count trend for Creative Enzymes

Uncover Creative Enzymes' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Creative Enzymes include Debut, Codexis and EnginZyme. Here is the list of Top 10 competitors of Creative Enzymes, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Debut 2019, San Diego (United States), Series B	Provider and manufacturer of enzymes for biotherapeutic creation and modification	$126M	Material Impact, KdT Ventures & 16 others	63/100
2nd	Codexis 2002, Redwood City (United States), Public	Developer of high-performance enzymes for drug discovery	$111M	Vivo Capital, Malaysian Life Sciences Capital Fund ... & 12 others	62/100
3rd	EnginZyme 2014, Stockholm (Sweden), Series B	Developer of immobilized enzymes	$42.3M	Industrifonden, Sofinnova Partners & 8 others	54/100
4th	Immobazyme 2019, Stellenbosch (South Africa), Series A	Developer of enzyme immobilisation technology	$2.9M	UTF, Fireball Capital & 2 others	53/100
5th	Genovis 1999, Lund (Sweden), Public	Develps enzymes for antibodies	-	Northislet, Hansa Biopharma	52/100
6th	Allozymes 2019, Singapore (Singapore), Series A	Developer of enzyme engineering platform for biosolutions across diverse industries	$20M	Seventure Partners, Xora Innovation & 8 others	49/100
7th	Twelve Bio 2019, Copenhagen (Denmark), Acquired	Developer of CRISPER technology based diagnostics and therapeutics	$2.57M	Arix Bioscience, BioInnovation Institute	45/100
8th	Creative Enzymes 2011, New York City (United States), Unfunded	Enzymes, probiotics, and extracts for research, diagnostics, and industrial applications	-	-	43/100
9th	New England Biolabs 1970, Ipswich (United Kingdom), Funding Raised	Molecular biology reagents company	-	NIH SBIR/STTR, Massachusetts Life Sciences Center ... & 2 others	43/100
10th	Nucleus Biologics 2016, San Diego (United States), Funding Raised	Cell culture solutions provider accelerating cell and gene therapy development	-	-	41/100